Recent studies have reported that an abnormal increase in GSK-3β is found in in vitro and in vivo models of ALS, in the thoracic spinal cord tissue of patients with sporadic ALS [13], and in the frontal and temporal cortices of ALS patients. Here, GSK3B is linked to amyotrophic lateral sclerosis.